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Abstract
Background: Cellular contractility, essential for cell movement and proliferation, is regulated by microtubules, RhoA and
actomyosin. The RhoA dependent kinase ROCK ensures the phosphorylation of the regulatory Myosin II Light Chain (MLC)
Ser19, thereby activating actomyosin contractions. Microtubules are upstream inhibitors of contractility and their
depolymerization or depletion cause cells to contract by activating RhoA. How microtubule dynamics regulates RhoA
remains, a major missing link in understanding contractility.
Principal Findings: We observed that contractility is inhibited by microtubules not only, as previously reported, in adherent
cells, but also in non-adhering interphase and mitotic cells. Strikingly we observed that contractility requires ubiquitin
mediated proteolysis by a Cullin-RING ubiquitin ligase. Inhibition of proteolysis, ubiquitination and neddylation all led to
complete cessation of contractility and considerably reduced MLC Ser19 phosphorylation.
Conclusions: Our results imply that cells express a contractility inhibitor that is degraded by ubiquitin mediated proteolysis,
either constitutively or in response to microtubule depolymerization. This degradation seems to depend on a Cullin-RING
ubiquitin ligase and is required for cellular contractions.
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Introduction
Cellular contractility and the ability of cells to change their
shape are prerequisites for many biological phenomena such as
cytokinesis, movement, differentiation and substrate adherence.
These changes in cell shape are achieved by modulation of the
cytoskeleton, most importantly the actin cytoskeleton, through
forces generated by the actomyosin network. This network is
regulated mainly through the activity of proteins from the Rho-
GTPase family that regulate both actin nucleation and myosin
activity through downstream effectors such as mDia and ROCK
(Rho kinase), respectively (reviewed by [1,2,3]). Cell contractility is
typically achieved by localized activation of Myosin II Light Chain
(MLC) by its phosphorylation on Ser19. This phosphorylation,
which causes contractions of the actin network by Myosin II is
regulated by various MLC kinases and Myosin phosphatase
(MYP). This site is phosphorylated by MLCK and ROCK [4],
ZIP kinase [5] and citron kinase [6]. In addition to direct
phosphorylation of Ser19, ROCK also phosphorylates and
inactivates myosin phosphatase (MYP) enabling the maintenance
of Ser19 phosphorylation. Inhibition of ROCK kinase inhibits
contractility and Ser19 phosphorylation [7].
Less is known about the diverse upstream pathways through
which RhoA acquires information from the cell’s external and
internal environments. It has been known for many years that
depolymerization of microtubules leads to elevation of cell
contractility, suggesting an inhibitory effect of microtubules on
the actin cytoskeleton [8,9]; reviewed by [10,11]). It has also been
shown that the microtubule polymerization inhibitor nocodazole
induces RhoA activation [12]. This inhibition leads to the
activation of MLC through ROCK by the release of the MAP
GEF-H1 [13,14].
RhoA is crucial for cytokinesis, where its local activation at the
cell cortex determines the positioning of the cleavage furrow
[15,16,17]. The major activator of RhoA in cytokinesis is the
proto-oncogene RhoGEF Ect2 [18]. Inhibition of Ect2 leads to
failure of cytokinesis and to binucleated cells ([19] and our
unpublished results). Microtubules have been proven to have a
crucial role in regulating cleavage furrow positioning, but the
mechanism and microtubule effect on this process are still a matter
of debate [20].
This project was initiated by our observation that cells arrested
with nocodazole in prometaphase undergo vigorous contractions.
We used time lapse microscopy to study these contractions and
observed that they are not cell cycle specific and take place in non
adhering cells throughout the cell cycle. These contractions were
indeed sensitive to a variety of inhibitors of the RhoA pathway that
we applied such as treatments with the exoenzyme C3 transferase,
knockdown of Ect2 activity, expression of dominant negative
RhoA and inhibition of ROCK with Y27632. We further showed
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6155that the RhoA-GEF Ect2, known to play a role in cytokinesis, also
regulates contractions, at least as far as early mitotic cells are
concerned.
The question how microtubule depletion activates the RhoA
pathway remains a major unanswered issue. Given the major role
of ubiquitination in most cellular events, we tested whether
contraction activation requires ubiquitination. We used a
proteasomal inhibitor and a cell line with temperature sensitive
ubiquitin activating enzyme (E1). To our surprise we observed that
ubiquitination and proteasomal degradation are required not for
the activation but for the inhibition of contractility. The largest
group of ubiquitin ligases in the cell constitutes of the Cullin-
RING type. This vast group comprises among others the seventy
different SCF (Skp1, Cul1, F-box proteins) complexes encoded by
the human genome, and possibly more then a hundred Cul3-BTB
based ligases [21]. To test whether such an ubiquitin ligase is
involved in inhibition of contractility we took advantage of a cell
line with a temperature sensitive neddylation pathway [22,23].
Nedd8 is an ubiquitin like protein that gets covalently conjugated
to lysine residues. Unlike ubiquitin it does not seem to form chains
or lead to proteolysis. So far the only known substrates of
neddylation are Cullins, subunits of the Cullin-RING ubiquitin
ligases. Cullin neddylation prevents the binding of the CAND1
inhibitor and is essential for the activity of these ligases [24]. We
show that myosin II light chain Ser19 phosphorylation, the most
direct downstream event required for all types of contractility,
strongly depends on proteolysis, ubiquitination and neddylation.
Results
Depolymerization of microtubules induces contractility
in non-adhering cells
The microtubule cytoskeleton inhibits contractility of adherent
cells in interphase [8,9], probably by sequestering the microtubule
associated protein GEF-H1 [13,14]. Enhanced contractility is
manifested by increased number and size of focal adhesions [25].
We studied the role of microtubules in the inhibition of
contractility of non-adhering cells - cells that grow constitutively
in suspension and adherent cells that were detached artificially or
became detached during mitosis.
Nocodazole impairs the capacity of a-tubulin to polymerize and
rapidly shifts the dynamic equilibrium of microtubules to a de-
polymerized state (Movie S1). We chose chicken DT40 B-cells that
grow in suspension (Movie S2A), to test the effect of microtubule
depolymerization on contractility. Movie S2B shows that treat-
ment of these cells with nocodazole rapidly led to contractions of
the entire cell population. This suggested that contractions are not
cell cycle dependent. Indeed DT40 cells synchronized at various
stages of the cell cycle all underwent contractions upon nocodazole
treatment (data not shown).
We wondered how adherent cells that become detached behave
upon microtubule depolymerization. We therefore detached
NIH3T3 cells from tissue culture dishes and observed their
attachment to glass cover slips in the presence or absence of
nocodazole. Without nocodazole the cells attached to the glass
within one hour while in the presence of nocodazole they failed to
attach for more than two hours and underwent vigorous
contractions (Figure 1 and Movie S3).
During mitosis the microtubule cytoskeleton undergoes a radical
change of its shape, composition and dynamics. We thus
wondered if it retains its capacity to inhibit cellular contractions.
Such an observation would be of significance for the capacity of
cells to undergo furrowing in cytokinesis. To follow the behavior of
the spindle we generated a NIH3T3 mouse fibroblast cell line that
stably expresses a-tubulin fused to the mCherry [26] fluorescent
protein (Figure 2 and Movie S1). We treated these cells with
nocodazole and followed them by time lapse microscopy.
Figure 2B and Movie S4B show that as long as cells were in
interphase they remained attached to the matrix and did not
visibly contract. Upon reaching prometaphase they detached from
the matrix, as expected from mitotic cells, and initiated
contractions at multiple random locations. Cells arrested at this
Figure 1. Detached adherent cells contract in a microtubules dependent manner. Unsynchronized NIH3T3 cells were trypsinized and
plated in glass bottom dishes with (bottom panels) or without nocodazole (top panels). While control cells flattened within 30–60 minutes,
nocodazole-treated cells failed to re-attach for more than 2 hours and during this time they continued to contract vigorously.
doi:10.1371/journal.pone.0006155.g001
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We thus concluded that microtubule depolymerization induces
contractility throughout the cell cycle.
We next asked whether microtubule stabilization would induce
an inhibitory effect on contractility. This was achieved by
inhibiting a-tubulin depolymerization with Paclitaxel (taxol).
Treated cells exhibited thick and rigid microtubule bundles. Like
in the case of nocodazole, taxol-treated cells arrested in
prometaphase by the SAC. This arrest had either of two
phenotypes. The majority of the cells exhibited rigid spindles,
did not contract but arrested as motionless round mitotic cells for
several hours until they flattened, presumably due to mitotic
slippage [27] (Figure 2C). About a fifth of the cells, however, failed
to assemble spindles and underwent contractions similar to those
demonstrated by nocodazole treated cells (Figure 2D). The reason
for that is unknown but we speculate that this is because taxol
interferes with the dynamic instability of microtubules which in
some cases resulted in the collapse of the microtubule cytoskeleton
(Figure 2D timepoint 3.5 hours).
The cells discussed so far were treated for several hours in
interphase with the indicated drugs until they reached prometa-
phase. Since these drugs arrest the cells at the SAC, we sought an
alternative method to arrest cells later in mitosis, allowing the
spindles to form normally and test the instant effect of their de-
polymerization. To this end we transiently transfected cells with an
expression vector for a destruction box mutant of full length Cyclin
B1-GFP (Cyclin B1-DM-GFP), which is not ubiquitinated by the
APC/C and is thus not degraded. These cells arrested in mitosis
either before metaphase or in anaphase [28,29,30]. Figure 3 and
Movie S5A show that Cyclin B1-DM-GFP expressing cells formed
a normal spindle and maintained it for a very long time (Figure 3
top panel). These cells did not slip through the SAC for at least
48 hours, demonstrating that SAC slippage occurs indeed due to
APC/C specific Cyclin B1 degradation. When Cyclin B1-DM-
Figure 2. Mitotic NIH3T3 cells contract in a microtubule dependent manner. NIH3T3 cells stably expressing mCherry-a-tubulin were treated
with various drugs that affect microtubule dynamics. Left panels phase, right panel mCherry-a-tubulin. A. An untreated cell undergoes mitosis within
an hour (selected time points taken from Movie S4A). B. The effect of nocodazole on the microtubule network in interphase and mitosis. Time 0
shows the microtubule network, which has been disrupted following nocodazole addition (20 minutes, see also Movie S1). At 7 hours the cell entered
mitosis and immediately contracted for the following 6 hours (selected time points taken from Movie S4B). C. Shows a cell with a spindle formed in
the presence of taxol (80% of the treated cells). Taxol was added an hour after time 0. A thick and rigid microtubule pattern was observed within one
hour. Upon mitotic entry (2.5 hours) the cell formed a spindle that was apparent for the next 5.5 hours (arrowhead). During this time the cell did not
contract. Only after 8 hours the cell flattened while the spindle was still visible (arrowhead). D. Represents a less common effect of taxol (20% of the
treated cells), which does not lead to spindle assembly. Taxol was added an hour after time 0 and the cell entered mitosis at 3.5 hours. This cell did
not form a spindle and furrowed for 4.5 hours until it flattened at 8 hours.
doi:10.1371/journal.pone.0006155.g002
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started to contract, and kept contracting for many hours (Movie
S5B). Strikingly when the spindle in Cyclin B1-DM-GFP arrested
cells drifted to one part of the cell, the part of the cell distal to the
spindle promptly started to contract. When the spindle drifted
back contractions stopped upon approach of the spindle (Figure 3
central and bottom panels and Movie S5A). We observed this kind
of drifting and contractions of the distal part of the cell in 13 out of
the 64 cells. Contractions were never observed in proximity to the
spindle.
We further used monastrol, which arrest the cells in mitosis with
mono-astralspindles without interfering with microtubule dynamics
[31]. Monastrol treated cells did not contract but promptly started
to do so upon treatment with nocodazole (table 1). The contractility
we observed is thus not a mere effect of drugs interfering with
microtubule dynamics, but occurs in regions of the cell that have
become depleted of microtubules by other causes as well.
The results we report here show that cells that are not attached
to a matrix will undergo contractions upon microtubule depletion
whether they grow constitutively in suspension, are artificially
detached in interphase, or physiologically in mitosis. We thus
conclude that both the interphase microtubule cytoskeleton and
the mitotic spindle inhibit cellular contractility. A detailed
breakdown of these results and quantitative data is presented in
table 1.
Contractility induced by microtubule depolymerization
depends on the RhoA pathway
Cellular contractility by actomyosin depends on the RhoA
signaling pathway. We wanted to verify that the contractions
induced by microtuble depolymerization also depend on this
pathway. Cells were immuno-stained for RhoA and Myosin.
Figure 4 shows that indeed Myosin and RhoA localized to the
furrows that formed in contracting cells in a manner similar to
their localization to the cytokinetic cleavage furrow. The RhoA
localized to these furrows is likely to be in its active form [32,33].
We used a variety of methods to inhibit the different stages of the
RhoA pathway. RhoA was inhibited by the exoenzyme C3
transferase and ROCK was inhibited by the Y27632 inhibitor. In
both cases contractions in response to nodocazole treatment were
completely eliminated (table 2). We further transfected cells with a
vector expressing the dominant negative RhoA T19N mutant. In
the experiment shown in Figure 5 and Movie S6 an expressing and
a non-expressing cell are shown side by side. The transfected cell
did not contract while its non-expressing neighbor contracted
vigorously. Finally we tested the effect of inhibition of the Ect2
GEF, which is known to activate RhoA in cytokinesis. Both a
dominant negative expression vector and relatively modest siRNA
mediated knockdown of Ect2 (60%, Figure S1A-C) completely
eliminated contractions. Figure S1D shows that this relatively
modest knockdown was also sufficient for perturbing cytokinesis
resulting in many binucleated cells. All these experiments,
summarized in table 2, show that nocodazole induced contractions
fully depend on the RhoA signaling pathway. They also indicate
that these contractions are not ‘‘membrane blebbing’’ events but
cortical contractions involving RhoA and actomyosin activation.
Contractility requires ubiquitin dependent proteolysis by
a Cullin-RING ubiquitin ligase
Ubiquitin mediated proteolysis plays a role in most cellular
events. We observed that ubiquitin is localized to the furrows
formed in the absence of microtubules as well as in the cleavage
furrow during cytokinesis (our unpublished data) and we wondered
whether ubiquitin mediated proteolysis is also involved in
regulation of contractility. We therefore treated cells with
nocodazole together with the proteasome inhibitor MG132.
Figure 6 and Movie S7A show that MG132 treatment completely
abolished contractions of prometaphase arrested cells. Strikingly,
when cells that were already arrested with nocodazole in mitosis
and undergoing contractions were treated with MG132 they
stopped to contract within 7 hours. We wondered whether cells
stopped contracting due to a non specific irreversible harm caused
by MG132. We therefore washed cells that were arrested for
15 hours with MG132 and nocodazole and re-plated them into
fresh medium. Movie S7B shows that these cells resumed
contractility and attached to the matrix within two hours
precluding an irreversible harm. These findings suggest the
Figure 3. The mitotic spindle in cells arrested by nondegrad-
able Cyclin B1 inhibits contractions in a spatial dependent
manner. NIH3T3 cells stably expressing mCherry-a-tubulin were
transfected with Cyclin B1-DM-GFP. This Figure shows frames of three
selected time points taken from Movie S5A. Following mitotic entry and
spindle formation (2 hours, arrow) a part of the cell, which was distal to
the spindles (3.5 hours, arrowhead) started to contract, while a part of
the cell that remained proximal to the spindle did not (5 hours).
doi:10.1371/journal.pone.0006155.g003
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contractility.
Proteasomal inhibition leads to cell cycle arrest at various
phases. The requirement for proteasomal activity for contractions
could thus be due to cell cycle effects. To address this possibility,
we treated unsynchronized DT40 cells with nocodazole together
with MG132. This double treatment completely abolished
contractions regardless of cell cycle stage (table 3). The
Table 1. Cell contractility is induced by microtubule depolymerization.
Cells Treatment Effect Contractions Figure Movie Quantization*
DT40 Nocodazole Microtubule depolymerization Yes S2B 89% n=70
Detached NIH3T3 1S 3 .97% n<100
Mitotic NIH3T3 2B S4B 85% n=186
NIH3T3 Taxol Microtubule stabilization With spindle – No 2C 80% n=57
Without spindle - Yes 2D 20% n=57
NIH3T3 Cyclin B1-DM Metaphase/Anaphase arrest Close to spindle – No Far
from spindle - Yes
3 S5A 100% n=64 20% n=64
Cyclin B1 DM
+Nocodazole
Metaphase/Anaphase arrest+
Microtubule depolymerization
Yes S5B 92% n=135
NIH3T3 Monastrol Monopolar spindles due to Eg5
inhibition and lack of centrosome
separation
No 89% n=65
NIH3T3 Monastrol+Nocodazole Monopolar spindles followed by
microtubule depolymerization
Yes 84% n=71
*The percentage refers to the phenotype declared in the contractions column.
doi:10.1371/journal.pone.0006155.t001
Figure 4. Myosin and active RhoA localize to invaginations formed by contractions. Myosin heavy chain – B (MHC-B) and active RhoA are
localized to the cleavage furrow and midbody as well as to the contraction invaginations of nocodazole-treated mitotic cells (arrowheads). A–D,
DT40 cells; E–H NIH 3T3 cells; A, E, C, G control untreated cells; B, D, F, H, nocodazole-treated cells.
doi:10.1371/journal.pone.0006155.g004
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mitotic cells and does not require arrival at specific cell cycle
phases.
To verify the need for ubiquitin-mediated proteolysis in a non-
drug dependent manner we used the balb/c 3T3 derived mouse
fibroblast cell lines A31N-wt and A31N-ts20. The latter expresses
a thermo-sensitive E1 ubiquitin activating enzyme that becomes
inactive at the restrictive temperature of 39.5uC [34]. Wild type
A31N cells cultured either at 34uC (not shown) or 39.5uC (Movie
S8A) divided normally. Upon addition of nocodazole to the
growth medium the cells arrested at the SAC and started
contracting (Movie S8B). A31N-ts20 cells behaved like wild type
A31N cells at 34uC (Movie S8C). However when A31N-ts20
mutants were grown at 39.5uC for 8–14 hours and treated with
nocodazole the cells that reached mitosis arrested as round cells,
did not contract and did not flatten (Movie S8D). These findings
indicate that the ubiquitination pathway is required for contrac-
tility induced by microtubule depolymerization.
Cullin-RING complexes are the largest group of ubiquitin
ligases and are involved in the regulation of many cellular
pathways [21]. To test whether they are required for contractility
we used the hamster cell line E36-ts41 [23,35], which has a
temperature sensitive neddylation pathway [22]. Nedd8 is an
ubiquitin-like protein that is covalently conjugated to members of
the Cullin subunit of E3 ligases. This modification is essential for
the activation of Cullin-RING E3s [24]. We used the E36-ts41 and
its parental wild type E36-wt line to test if a Cullin-RING E3
mediates the ubiquitination that is required for contractions. Wild
type E36 cells divided normally both at 34uC (not shown) and
39.5uC (Movie S9A). Upon treatment with nocodazole these cells
arrested at the SAC, contracted and flattened within a few hours
(Movie S9B). Mutant E36-ts41 behaved at 34uC like wild type cells
(Movie S9C) and at 39.5u they arrested and did not divide (Movie
S9D). When the incubation temperature for E36-ts41cells was
shifted from 34uC to 39.5uC and nocodazole was added, the cells
that entered mitosis from 8 hours and onwards did not contract
(Movie S9E). Interestingly the minimal incubation time at the
restrictive temperature, required for the elimination of contrac-
tions, was almost identical for both the ts20 and the ts41 cells
(8 hours) and for MG132 (7 hours). The results of these
experiments and quantitative data are summarized in table 3.
These mutant cells enabled us also to test the requirement for
neddylation for contractility in detached interphase cells. We
plated E36-wt and E36-ts41 cells on glass in the presence of
nocodazole at the restrictive temperature of 39.5uC. E36-wt cells
contracted vigorously like the NIH3T3 cells shown in Figure 1 and
Movie S3, and began to flatten after 4 to 8 hours (Figure 7 upper
row and left panel of Movie S9F). E36-ts41 contracted initially for
about 10 hours and then ceased to contract but arrested as round
cells and did not flatten (Figure 7 lower row and right panel of
Movie S9F), demonstrating that these contractions are neddylation
dependent. This observation shows that neddylation is required for
contractions in a cell cycle independent manner. In a control
experiment without nocodazole both E36-wt and E36-ts41 cells
plated on glass incubated at either temperature flattened within 2–
4 hours (data not shown).
Phosphorylation of Ser19 of MLC requires proteolysis,
ubiquitination and neddylation
The most downstream regulatory event of cellular contractility is
the activating phosphorylation of Ser19 of MLC. The data presented
so far suggested that microtubules inhibit contractility and upon relief
the contractility requires ubiquitin mediated proteolysis by a Nedd8
dependent pathway. In order to assess whether this requirement
directly impinges on the phosphorylation of this site we used anti-
phospho Ser19 MLC antibodies. We addressed this issue with all
three treatments. First we analyzed the effect of inhibition of
proteolysis in human HeLa cells. Cells were detached from the tissue
culture dishes and treated with nocodazole for five hours with or
without MG132. Preliminary experiments have shown that detach-
ment induces Ser19 phosphorylation, which gets further enhanced by
nocodazole. Figure 8A shows that Ser19 phosphorylation was almost
completely eliminated by treatment of cells with MG132. Next we
analyzed Ser19 phosphorylation in the mouse A31N-ts20 cell line at
the permissive versus the restrictive temperature. Figure 8B shows
that phosphorylation wasdrastically reduced in A31N-ts20 cellsat the
restrictive temperature. In the wild type control cells, Ser19
phosphorylation was invariant to temperature. Finally we performed
a similar analysis in E36-ts41 cells and here too it isevident that Ser19
phosphorylation is much lower at the restrictive temperature of the
mutant cells and not affected in wild type controls (Figure 8C). These
results clearly show that proteolysis, ubiquitination and neddylation
are required for Ser19 phosphorylation.
Constitutively active RhoA overrides the requirement of
ubiquitination for contractions
We have shown that contractions depend both on the RhoA
pathway and on the activity of a Cullin-RING E3. To establish the
Table 2. Cell contractility requires the RhoA pathway.
Cells Nocodazole+ Microtubule depolymerization+ Contractions Quantization*
NIH3T3 Yes 85% n=186
NIH3T3 Y27632 Inhibition of ROCK No 91% n=54
NIH3T3 Exoenzyme C3 transferase Inhibition of RhoA No 70% n=95
NIH3T3
** dnRhoA Inhibition of RhoA No 93% n=40
NIH3T3 ECT2 knockdown Inhibition of Ect2 No 87% n=80
NIH3T3 dnECT2 siRNA knockdown Inhibition of Ect2 No
DT40 Yes 89% n=70
DT40 Y27632 ROCK inhibition No 85% n=46
DT40 Exoenzyme C3 transferase RhoA inhibition No 74% n=50
*The percentage refers to the phenotype declared in the contractions column.
**Figure 5 and Movie S6.
doi:10.1371/journal.pone.0006155.t002
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with an expression vector for a constitutively active form of RhoA
(Q63L-hRhoA) fused to GFP (caRhoA-GFP) and cultured them at
39.5uC in the presence of nocodazole. Under these conditions
protein degradation, which is mediated by Cullin-RING ubiquitin
ligases, is blocked while the RhoA pathway is active. Figure 9 and
Movie S10 show that untransfected cells did not contract, while
caRhoA-GFP expressing cells vigorously contracted. This suggests
that RhoA activity is downstream to the Cullin-RING E3 and
might be dependent on it for contracting. This experiment also
verifies that loss of contractions in response to neddylation
inhibition is a rather specific event and not a result of ATP
depletion in cells.
We searched for potential candidate proteins that inhibit RhoA
and contractility and that are degraded in response to microtubule
de-polymerization. The RhoA inhibitor p190RhoGAP that is
degraded during the cell cycle [33], could have been a suitable
candidate. We observed however that p190RhoGAP is not
degraded in response to microtubule depolymerization. These
findings thus exclude it from being the inhibitor we are currently
seeking (data not shown).
Discussion
In this study we addressed the regulation of cellular contractility, a
behavior of major importance for cell movement and proliferation.
Contractility in response to microtubule depolymerization has been
observed already 20 years ago [8,9]. Our research has extended these
observations to non-adhering cells and to cells during mitosis. These
observations are in agreement with a recent report of contractions of
non-adhering cells and of cell fragments [36].
We show that movement of the mitotic spindle can induce
contractility also in the absence of drugs. This observation stresses
the importance of the spindle in the inhibition of contractions, and
is reminiscent of the effect observed in response to manual
manipulations of the spindle of echinoderm embryos [15]. Such
observations are of significance for the ongoing debate whether the
cytokinetic furrow is actively induced by the spindle midzone, or
Figure 5. Inhibition of RhoA inhibits nocodazole-induced
contractions. NIH3T3 cells stably expressing mCherry-a-tubulin were
transfected with pEGFP-hRhoA T19N (dnRhoA-GFP) and treated with
nocodazole. The left panel shows the mCherry2a-tubulin pattern and
the right panel shows dnRhoA-GFP expression. Two cells can be seen: a
dnRhoA-GFP transfected cell (arrow) and an untransfected cell
(arrowhead). They both entered mitosis at about the same time
(9.5 hours). While the dnRhoA-GFP expressing cell remained arrested for
5 hours and did not contract, the non transfected adjacent cell
contracted vigorously (see also Movie S6).
doi:10.1371/journal.pone.0006155.g005
Figure 6. Cellular contractility requires proteasome-mediated
degradation. This NIH3T3 cell was treated with nocodazole, entered
mitosis and contracted prior to the addition of MG132 at time 0. The
cell ceased to contracted after several hours (7.5 and 10.5 hours, see
also Movie S7A).
doi:10.1371/journal.pone.0006155.g006
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place furthest away from the microtuble organizing centers
[20,37,38]. While our results support the latter model, they do
not directly contradict the first and the possibility that the
mechanisms that regulates cytokinetic furrow initiation differ from
the mechanism presented in this work.
Niiya et al [39] showed that Cdk1 inactivation in early mitosis
can leads to precocious cytokinesis. Their observations however do
not imply that Cdk1 inactivation is essential for contractions. We
have shown here that contractions can take place anytime during
the cell cycle, some of which will have low others high levels of
Cdk1 activity. As a matter of fact most of the contractions
described here took place in prometaphase arrested cells, which
have high levels of Cdk1 activity.
We confirmed here that cellular contractility induced by
microtubule depolymerization depends, as previously reported
[40,41], on the RhoA-ROCK pathway. The RhoA GTPase
requires also a GEF for its activation. GEF-H1 has been
implicated in contractility in the past [13,14]. The RhoA-GEF
Ect2 is considered to be specific for activation of RhoA in
cytokinesis [18,20]. We observed that Ect2 is essential for
contractility during early mitosis. As Ect2 is present during all
stages of the cell cycle [18] and our data (not shown), it could
indeed control contractility also in interphase.
Our observation, that contractility requires ongoing ubiquitin
mediated proteasomal degradation, is highly significant. Its
requirement for neddylation suggests that degradation is most
likely mediated by a Cullin-RING ubiquitin ligase. Our results
imply that the cell is continuously synthesizing a protein that
inhibits contractility and that must be degraded for cells to
contract. Potapova et al. [42] have shown that, as long as Cdk1
activity is inhibited, proteasomal activity is not required for
cytokinesis. In their experiments the proteasome was inhibited for
less than an hour. All the approaches we used show that the re-
accumulation and effect of the yet unknown contractility inhibitor
take roughly seven hours. This response is relatively slow
compared to other cellular events. As a matter of fact this time
span is reminiscent of the time it takes tissue culture cells arrested
prior to the restriction point [43] to exit G0 in response to
stimulation by growth factors [44]. Such a prolonged inhibition of
proteasomal degradation could potentially lead to non physiolog-
ical stress and possibly to depletion of ATP. Experiments shown in
Figure 9 and Movie S10 make such an explanation unlikely. Cells
with an inhibited neddylation pathway expressing a dominant
Table 3. Cell contractility requires ubiquitin mediated degradation.
Cells
Treatment
Nocodazole +
Effect Microtubule
depolymerization+ Contractions Figure Movie Quantization*
NIH3T3 MG132 Proteasome inhibition No 6 S7 80% n=35 88% n=17
A31N-wt 39.5
0 Yes S8B 92% n=48
**
A31N-ts20 34
0 Yes S8C 90% n=51
**
A31N-ts20 39.5
0 E1 inhibition No S8D 94% n=48
E36-wt 39.5
0 Yes S9B 92% n=50
**
E36-ts41 34
0 Yes S9C 90% n=48
**
E36-ts41 39.5
0 Neddylation inhibition No S9E 94% n=46
E36-wt 39.5
0*** Yes S9F .97% n<100
E36-ts41 39.5
0*** Neddylation inhibition No S9F .97% n<100
DT40 MG132 Proteasome inhibition No 81% n=67
*The percentage refers to the phenotype declared in the contractions column.
**Mitotic cells that vigorously furrowed for any length of time.
***Detached cells were seeded on glass bottom culture plate.
doi:10.1371/journal.pone.0006155.t003
Figure 7. Contractility requires neddylation. Trypsinized E36-wt and E36-ts41 (upper and lower panels respectively) cells, normally incubated at
34uC, were treated with nocodazole and plated in glass bottom dishes at 39.5uC. Control E36-wt cells vigorously contracted for 8–10 hours and then,
within the next 13 hours of incubation, and gradually flattened (10, 13, 17, 21 hours). E36-ts41 cells contracted as the control cells for the first
10 hours and then gradually contraction ceased. This 10 hours time point corresponds to the time necessary for the thermosensitive mutation to
become active and reflects the residual neddylation which existed prior to the temperature shift. Moreover, these round and motionless cells failed to
re-adhere the plate (time points 13, 17, 21 hours and Movie S9F).
doi:10.1371/journal.pone.0006155.g007
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neighbors. This indicates that lack of ATP or a non specific effect
are unlikely to lead to the cessation of contractions in these cells.
Movie S7B shows that cells inhibited for a prolonged time in
MG132 recover and resume contractile behavior once they are
washed and transferred to MG132 free medium.
A particular intriguing possibility is that degradation can be
modulated or inhibited by the cell under conditions where cells are
not supposed to contract, to move, or to divide. It would be of
interest to establish whether terminally differentiated cells in tissues
that are neither supposed to divide nor to wander around still
degrade this inhibitor.
The hypothetical model we propose described in Figure 10
suggests that this inhibitor is degraded in response to microtubule
depolymerization. It is however also possible that degradation is
ongoing and that the inhibitory mechanisms act in parallel. We
show that this degradation directly impinges on the phosphory-
lation of Ser19 of Myosin II light chain. As ROCK and other
kinases directly phosphorylate MLC Ser19, it is conceivable that
the inhibitor acts upstream. Indeed expression of constitutively
active RhoA managed to override this inhibition. We don’t have
however evidence that the inhibitor acts directly on the RhoA
pathway.
The search for this inhibitor and the characterization of its
degradation are a major challenge for future studies currently
underway in our lab. Inhibition of such a mechanism by
specifically developed drugs can be a useful and highly specific
approach to inhibit cell movement and division, two hallmarks of
metastasizing cancer cells.
Materials and Methods
Cells, cell culture and reagents
NIH-3T3, E36-ts41, E36, A31N and A31N-ts20 cell lines were
maintained in Dulbecco’s modified Eagle medium (DMEM,
Gibco) containing 10% fetal calf serum, 10 u/ml Penicillin and
100 mg/ml Streptomycin (Biological Industries, Beit-Haemek).
DT40 cells were maintained in RPMI-1640 (Gibco) containing
10% fetal calf serum, 3% chicken serum, 10 u/ml Penicillin,
100 mg/ml Streptomycin and 50 mM 2-mercaptoethanol (Merck).
NIH3T3 and DT40 were grown at 37uC with 5% CO2. E36-wt,
E36-ts41, A31N-wt and A31N-ts20 were grown either at 34uCo r
at 39.5uC (as described in Results) in 5% CO2.
The reagents were added to the growing media to reach the
indicated final concentration as follows: nocodazole (Sigma) 2 mM
(0.2 mM for HeLa cells), Taxol (Sigma) 5 mM, MG132 (Sigma)
0.1 mM (0.05 mM for HeLa cells), Cell permeable exoenzyme C3
transferase (Cytoskeleton) 7.5 mg/ml, Y27632 (Sigma) 15 mM.
Ect2 siRNA (Santa Cruz Biotechnology sc-35259), non-specific-
siRNA and siRNA delivery control (Mirus) were transfected using
Lipofectamine 2000 (Invitrogene) according to manufacturer
guidelines.
DNA cloning and plasmid constructs
The pEF-Cyclin B1DM-GFP vector expressing non degradable
full-length mouse Cyclin B1-GFP was previously described [45].
pEGFP-hRhoA T19N (dnRhoA) and pEGFP-hRhoA Q63L
(caRhoA) were a gift from S. Ravid. pEGFP-Ect2-N1 (dnEct2)
[46] was a gift of S. Narumiya.
pEF-mCherry-a-tubulin was made by Y. Oren by cloning a-tubulin
downstream and in frame with the gene for the mCherry fluorescent
protein [26] in the pEF-plink2 expression vector. All vectors were
sequenced and verified. Transient transfections and stable lines were
obtained by the CaPO4 co-precipitation method [47].
Antibodies and fluorescent labeling
Rabbit anti-pMLC (Cell Signaling) and Goat anti-actin (Santa
Cruz Biotechnology sc-1616) were used for western blotting.
Mouse anti-RhoA (26C4) (Santa Cruz Biotechnology sc-418)
diluted 1:200, Rabbit anti-mMHC-B (S. Ravid) diluted 1:200,
Figure 8. Proteolysis, ubiquitination and neddylation are
required for MLC phosphorylation. A, HeLa cells were suspended
by trypsinization and grown for five hours in suspension in plastic tubes
in the presence of nocodazole with or without MG132. Cells were
harvested and analyzed by western blot with anti-phosoho-myosin
antibodies. B, A31N-wt and A31N –ts20 cells were grown over-night at
the indicated temperatures. They were subsequently trypsinized and
grown in suspension in plastic tubes for an additional 2 hours in the
presence of nocodazole at the same temperatures. Cells were harvested
and analyzed by western blot with anti-phosoho-myosin antibodies. C,
E36-wt and E36-ts41 cells were grown over-night at the indicated
temperatures. They were subsequently trypsinized and grown in
suspension in plastic tubes for an additional 2 hours in the presence
of nocodazole at the same temperatures. Cells were harvested and
analyzed by western blot with anti-phosoho-myosin antibodies.
doi:10.1371/journal.pone.0006155.g008
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Donkey anti-Rabbit IgG (H+L) Cy2 (Jackson Immunoresearch).
RhoA immunofluorescent labeling was done as recently described.
For mMHC-B labeling, cells were fixed in 4% formaldehyde in
PBS for 20 minutes and blocked with PBST. The slides were
visualized either on an inverted IX70 Olympus microscope and
Figure 9. Neddylation is upstream of the RhoA pathway. E36-ts41 control cells or E36-ts41 mutant cells transfected with an expression vector
to the constitutively active RhoA mutant Q63L-hRhoA fused to GFP (caRhoA) (upper and lower rows respectably) were grown at 39.5uC in the
presence of nocodazole. While control cells did not contract, caRhoA-expressing cells contracted for 22 hours.
doi:10.1371/journal.pone.0006155.g009
Figure 10. Hypothetical model of regulation of cell contractility. The model shows how microtubule stability is upstream of the inhibitor.
Once microtubules are broken down or removed the inhibitor is degraded enabling the activation of the RhoA cascade. We included all the inhibitors
and mutants we used to test this hypothesis.
doi:10.1371/journal.pone.0006155.g010
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on an Olympus FV1000 confocal microscope. The images were
analyzed and assembled with Image pro plus 5.0 (Media
Cybernetic), ImageJ (http://rsb.info.nih.gov/ij/) and Photoshop
7 (Adobe) software. Movies were assembled by Premier-Pro
(Adobe).
Time lapse microscopy
Cells were seeded on 35 mm tissue culture plates (Nunc) a day
prior of filming. The cells were observed by an Axiovert 200 M
microscope (Zeiss) equipped with a CO2 and temperature-
controlled incubator (EMBL GP168) and SM1 motorized stage
(Luigs & Neumann). Images were captured with LD32X/0.4 air
or 40X/1.3 oil objective lenses using a SensiCam QE (PCO)
digital camera and CompiC Inject (Cell Biology Trading)
software.
Supporting Information
FigureS1 KnockdownofEct2results inbinucleatedcells. A.Ect2
siRNA reduce Ect2 levels in NIH3T3 total protein extract. Extracts
from mock, Ect2 siRNA and non-specific siRNA (NS-siRNA)
transfected cells analyzed by Western blotting. Only Ect2 siRNA
transfected cells show reduction in protein level. B–D, Immunos-
taning with anti-a-tubulin and anti ECT2 antibodies show that
while in the mock and the siRNA non-specific transfected cells
ECT2 level was not affected, ECT2 siRNA transfected cells had
much lower levels of ECT2. Commonly, these cells were also bi-
nucleated as they fail to undergo cytokinesis.
Found at: doi:10.1371/journal.pone.0006155.s001 (2.15 MB TIF)
Movie S1 Nocodazole leads to almost instantaneous microtu-
bule de-polymerization. NIH3T3 cells stably expressing mCherry-
a-tubulin subjected to nocodazole treatment. Microtubule disrup-
tion occurs within 4–8 minutes of nocodazole addition (108–
116 min).
Found at: doi:10.1371/journal.pone.0006155.s002 (1.29 MB AVI)
Movie S2 Non adherent DT40 cells contract throughout the cell
cycle in a microtubule-dependent manner. A. DT40 cell undergo
mitosis. B. Asynchronous culture treated with nocodazole
contracts vigorously.
Found at: doi:10.1371/journal.pone.0006155.s003 (3.49 MB AVI)
Movie S3 Detached adherent cells contract and fail to re-attach
in a microtubules- dependent manner. NIH3T3 cells detached by
trypsinization and allowed to re-adhere on a glass cover slip.
Control cells (left panel) flatten within 30–60 minutes. Nocodazole-
treated cells (right panels) contract and fail to re-adhere for at least
2 hours and usually flatten only after 4 hours.
Found at: doi:10.1371/journal.pone.0006155.s004 (2.26 MB AVI)
Movie S4 Microtubules inhibit contractility in NIH3T3 mitotic
cells. A, NIH3T3 cells stably expressing mCherry-a-tubulin
undergo normal mitosis within an hour. B, Nocodazole was
added one hour after the beginning of the movie. Seven hours
later the cell detached from the plate, entered mitosis and
immediately started to contract for more than 7 hours.
Found at: doi:10.1371/journal.pone.0006155.s005 (8.07 MB AVI)
Movie S5 The mitotic spindle in cells arrested by nondegradable
Cyclin B1 inhibits contractions in a spatial dependent manner. A,
NIH3T3 cells stably expressing mCherry-a-tubulin were trans-
fected with Cyclin B1-DM-GFP. Following mitotic entry and
spindle formation (arrow) a cell portion, which was distal to the
spindles (arrowhead) started to contract. When the spindle
approached the distal part the contractions stopped (224–
280 min). Phase (left panel), mCherry-a-tubulin (central panel),
Cyclin B1-DM-GFP (right panel). B, NIH3T3 cells stably
expressing mCherry-a-tubulin were transfected with Cyclin B1-
DM-GFP, as described in A. The part of the movie presented here
starts 20 hours after mitotic entry. After an additional 8.5 hours
the cells were treated with nocodazole, which led to prompt
spindle depolymerization and to vigorous contractions.
Found at: doi:10.1371/journal.pone.0006155.s006 (5.97 MB AVI)
Movie S6 Inhibition of the RhoA-ROCK signaling pathway
stops nocodazole induced contractions. NIH3T3 cells stably
expressing mCherry-a-tubulin were transfected with dnRhoA-
GFP and treated with nocodazole. A dnRhoA expressing cell
(arrow) entered mitosis as indicated by the nuclear envelope
breakdown (620 min), remained arrested for 5 hours and did not
contract. Note the non transfected adjacent cell that entered
mitosis earlier (568 min) and vigorously contracted.
Found at: doi:10.1371/journal.pone.0006155.s007 (6.23 MB AVI)
Movie S7 Nocodazole induced contractions depend on protea-
some activity. A. NIH3T3 cells stably expressing mCherry-a-tubulin
were treated with both nocodazole and the proteasome inhibitor
MG132. Nocodazole was added 4 hours before the beginning of the
movie. MG132 wasadded at the beginningofthe movie whilethecell
was already arrested and contracting. The cell continued to contract
for an additional 7.5 hours and then ceased and remained as an
arrested round mitotic cell. B. NIH3T3 cells where arrested for
15 hours with MG132 and nocodazole. They were subsequently
washed and released into fresh medium without inhibitors. The cells
seem to recover well and attach within about 2 hours.
Found at: doi:10.1371/journal.pone.0006155.s008 (7.43 MB AVI)
Movie S8 Nocodazole induced contractions depend on ubiqui-
tination. A31N-wt and A31N-ts20 cells were subjected to
nocodazole at the permissive and restrictive temperatures. A,
A31N-wt control cells undergo normal mitosis at 39.5u.B ,A n
A31N-wt cell grown at 39.5u was treated with nocodazole and
contracted upon mitotic entry. C, An A31N-ts20 cell grown at 34u,
was treated with nocodazole. The cell contracted for 7 hours
before it flattened. D, An A31N-ts20 cell was grown at 39.5u in the
presence of nocodazole for 13 hours before it entered mitosis
(788 min). During the next 14 hours the cell remained arrested,
did not contracted and did not flatten.
Found at: doi:10.1371/journal.pone.0006155.s009 (10.08 MB
AVI)
Movie S9 Nocodazole induced contractions depend on neddyla-
tion. E36-wt or E36-ts41 cells were treated with nocodazole at the
permissive and the restrictive temperatures. A, E36-wt control cells
undergo normal mitosis at 39.5uC. B, An E36-wt cell grown at
39.5uC was treated with nocodazole and contracted upon entry into
mitosis. C, An E36-ts41 cell grown at 34uC was treated with
nocodazole. The cell arrested and contracted for 4 hours before it
flattened. D, E6-ts41 cells undergo cell cycle arrest at 39.5uC. The
movie started at 34uC and the cell (arrow, 44 minutes) underwent
normal mitosis. Fifteen hours later the temperature was shifted to
39.5uC for an additional 11 hours. The cell was overall arrested for
at least 26 hours. The cell cycle time of these cells at 34uC is about
16 hours. E, Temperature shift to 39.5uC of nocodazole-treated,
mitotic E36-ts41 cells stopped their contractions. At the beginning
of the movie the temperature was shifted to 39.5uC and nocodazole
was added. Upon mitotic entry the cell (arrow, 52 minutes)
contracted for 14.5 hours (944 minutes), and then stopped for an
additional 4 hours. F, Detached control E36-wt (left panel) and
E36-ts41 (right panel) were allowed to re-adhere on a glass cover
slip. Nocodazole was added and the temperature was shifted to
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PLoS ONE | www.plosone.org 11 July 2009 | Volume 4 | Issue 7 | e615539.5uC at the beginning of the movie. While control cells contracted
and re-adhered within 4–8 hours, E36-ts41 cells contracted for
10 hours and then ceased. These cells failed to adhere the matrix.
Found at: doi:10.1371/journal.pone.0006155.s010 (10.17 MB
AVI)
Movie S10 Neddylation is upstream of the RhoA pathway. E36-
ts41 cells were transiently transfected with constitutively active
form of RhoA Q63L fused to GFP(caRhoA-GFP), grown at
39.5uC and treated with nocodazole. While the non-transfected
control cell on the left panel did not contract (see also movie 9E)
the transfected cell on the right panel vigorously contracted for
over 14 hours. This indicates that the neddylation process
required for contractility is upstream to the RhoA signaling
pathway. Moreover, this suggests that prolong blocking of
neddylation does not result in ATP depletion or in over activation
Myosin phosphatase.
Found at: doi:10.1371/journal.pone.0006155.s011 (5.42 MB AVI)
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